SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Andreas Buttgereit, Cornelia Weber, Oliver Friedrich, A novel quantitative morphometry approach to assess regeneration in dystrophic skeletal muscle, Neuromuscular Disorders, 2014, 24, 7, 596

    CrossRef

  2. 2
    S. A. Goonasekera, J. Davis, J. Q. Kwong, F. Accornero, L. Wei-LaPierre, M. A. Sargent, R. T. Dirksen, J. D. Molkentin, Enhanced Ca2+ influx from STIM1-Orai1 induces muscle pathology in mouse models of muscular dystrophy, Human Molecular Genetics, 2014, 23, 14, 3706

    CrossRef

  3. 3
    Christopher W. Ward, Benjamin L. Prosser, W. Jonathan Lederer, Mechanical Stretch-Induced Activation of ROS/RNS Signaling in Striated Muscle, Antioxidants & Redox Signaling, 2014, 20, 6, 929

    CrossRef

  4. 4
    E. R. Wissing, J. G. Boyer, J. Q. Kwong, M. A. Sargent, J. Karch, E. M. McNally, K. Otsu, J. D. Molkentin, P38  MAPK underlies muscular dystrophy and myofiber death through a Bax-dependent mechanism, Human Molecular Genetics, 2014,

    CrossRef

  5. 5
    Mun Chan, Glenn C Rowe, Srilatha Raghuram, Ian S Patten, Caitlin Farrell, Zolt Arany, Post-natal induction of PGC-1α protects against severe muscle dystrophy independently of utrophin, Skeletal Muscle, 2014, 4, 1, 2

    CrossRef

  6. 6
    Wanda M. Snow, Judy E. Anderson, Mark Fry, Regional and genotypic differences in intrinsic electrophysiological properties of cerebellar Purkinje neurons from wild-type and dystrophin-deficient mdx mice, Neurobiology of Learning and Memory, 2014, 107, 19

    CrossRef

  7. 7
    Juliano Alves Pereira, Cintia Yuri Matsumura, Elaine Minatel, Maria Julia Marques, Humberto Santo Neto, Understanding the beneficial effects of doxycycline on the dystrophic phenotype of the mdx mouse, Muscle & Nerve, 2014, 50, 2
  8. 8
    Gernot Schram, Anne Fournier, Hugues Leduc, Nagib Dahdah, Johanne Therien, Michel Vanasse, Paul Khairy, All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy, Journal of the American College of Cardiology, 2013, 61, 9, 948

    CrossRef

  9. 9
    Natalia Shirokova, Ernst Niggli, Cardiac phenotype of Duchenne Muscular Dystrophy: Insights from cellular studies, Journal of Molecular and Cellular Cardiology, 2013, 58, 217

    CrossRef

  10. 10
    Stephanie Duguez, William Duddy, Helen Johnston, Jeanne Lainé, Marie Catherine Le Bihan, Kristy J. Brown, Anne Bigot, Yetrib Hathout, Gillian Butler-Browne, Terence Partridge, Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion, Cellular and Molecular Life Sciences, 2013, 70, 12, 2159

    CrossRef

  11. 11
    Adriana Fogagnolo Mauricio, Elaine Minatel, Humberto Santo Neto, Maria Julia Marques, Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice, Clinical Nutrition, 2013, 32, 4, 636

    CrossRef

  12. 12
    Samara Camaçari de Carvalho, Leticia Montanholi Apolinário, Selma Maria Michelin Matheus, Humberto Santo Neto, Maria Julia Marques, EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype, Journal of Neuroimmunology, 2013, 264, 1-2, 41

    CrossRef

  13. 13
    Ramzi J. Khairallah, Sakthivel Sadayappan, Finding the missing link: Disulfide-containing proteins via a high-throughput proteomics approach, PROTEOMICS, 2013, 13, 22
  14. 14
    Andreas Buttgereit, Cornelia Weber, Christoph S Garbe, Oliver Friedrich, From chaos to split-ups – SHG microscopy reveals a specific remodelling mechanism in ageing dystrophic muscle, The Journal of Pathology, 2013, 229, 3
  15. 15
    James Tsao, Dolores A Vernet, Robert Gelfand, Istvan Kovanecz, Gaby Nolazco, Kevin W Bruhn, Nestor F Gonzalez-Cadavid, Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle, Stem Cell Research & Therapy, 2013, 4, 1, 4

    CrossRef

  16. 16
    Jessica R. Terrill, Hannah G. Radley-Crabb, Tomohito Iwasaki, Frances A. Lemckert, Peter G. Arthur, Miranda D. Grounds, Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies, FEBS Journal, 2013, 280, 17
  17. 17
    Christophe Hourdé, Pierre Joanne, Phillippe Noirez, Onnik Agbulut, Gillian Butler-Browne, Arnaud Ferry, Protective effect of female gender–related factors on muscle force-generating capacity and fragility in the dystrophic mdx mouse, Muscle & Nerve, 2013, 48, 1
  18. 18
    M. G. Morales, J. Gutierrez, C. Cabello-Verrugio, D. Cabrera, K. E. Lipson, R. Goldschmeding, E. Brandan, Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy, Human Molecular Genetics, 2013, 22, 24, 4938

    CrossRef

  19. 19
    Aphrodite Vasilaki, Malcolm J. Jackson, Role of reactive oxygen species in the defective regeneration seen in aging muscle, Free Radical Biology and Medicine, 2013, 65, 317

    CrossRef

  20. 20
    Olivier M. Dorchies, Julie Reutenauer-Patte, Elyes Dahmane, Hesham M. Ismail, Olivier Petermann, Ophélie Patthey-Vuadens, Sophie A. Comyn, Elinam Gayi, Tony Piacenza, Robert J. Handa, Laurent A. Décosterd, Urs T. Ruegg, The Anticancer Drug Tamoxifen Counteracts the Pathology in a Mouse Model of Duchenne Muscular Dystrophy, The American Journal of Pathology, 2013, 182, 2, 485

    CrossRef

  21. 21
    Jessica R. Terrill, Amber Boyatzis, Miranda D. Grounds, Peter G. Arthur, Treatment with the cysteine precursor l-2-oxothiazolidine-4-carboxylate (OTC) implicates taurine deficiency in severity of dystropathology in mdx mice, The International Journal of Biochemistry & Cell Biology, 2013, 45, 9, 2097

    CrossRef

  22. 22
    Benjamin L. Prosser, Ramzi J. Khairallah, Andrew P. Ziman, Christopher W. Ward, W.J. Lederer, X-ROS signaling in the heart and skeletal muscle: Stretch-dependent local ROS regulates [Ca2+]i, Journal of Molecular and Cellular Cardiology, 2013, 58, 172

    CrossRef

  23. 23
    Olivier Dorchies, Urs Ruegg, Green Tea Polyphenols, 2013,

    CrossRef

  24. 24
    Hannah Radley-Crabb, Jessica Terrill, Thea Shavlakadze, Joanne Tonkin, Peter Arthur, Miranda Grounds, A single 30min treadmill exercise session is suitable for ‘proof-of concept studies’ in adult mdx mice: A comparison of the early consequences of two different treadmill protocols, Neuromuscular Disorders, 2012, 22, 2, 170

    CrossRef

  25. 25
    Blain Alison, Greally Elizabeth, Laval Steve, Blamire Andrew, Macgowan Guy, Straub Volker, Animal Models of Duchenne Muscular Dystrophy, with Special Reference to the mdx Mouse, Biocybernetics and Biomedical Engineering, 2012, 32, 4, 3

    CrossRef

  26. 26
    Erika Tonon, Renato Ferretti, Jean Hideki Shiratori, Humberto Santo Neto, Maria Julia Marques, Elaine Minatel, Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice, Nutrition, 2012, 28, 6, 686

    CrossRef

  27. 27
    Tiffany C. Ho, Natalie A. Horn, Tuan Huynh, Lucy Kelava, Jeffry B. Lansman, Evidence TRPV4 contributes to mechanosensitive ion channels in mouse skeletal muscle fibers, Channels, 2012, 6, 4, 246

    CrossRef

  28. 28
    Marybeth Camboni, Sue Hammond, Laura T Martin, Paul T Martin, Induction of a regenerative microenvironment in skeletal muscle is sufficient to induce embryonal rhabdomyosarcoma in p53-deficient mice, The Journal of Pathology, 2012, 226, 1
  29. 29
    Victor H Morgenroth, Lauren P Hache, Paula R Clemens, Insights into bone health in Duchenne muscular dystrophy, BoneKEy Reports, 2012, 1,

    CrossRef

  30. 30
    R. J. Khairallah, G. Shi, F. Sbrana, B. L. Prosser, C. Borroto, M. J. Mazaitis, E. P. Hoffman, A. Mahurkar, F. Sachs, Y. Sun, Y.-W. Chen, R. Raiteri, W. J. Lederer, S. G. Dorsey, C. W. Ward, Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy, Science Signaling, 2012, 5, 236, ra56

    CrossRef

  31. 31
    Yoshiko Nakae, Olivier M. Dorchies, Peter J. Stoward, Benno F. Zimmermann, Christina Ritter, Urs T. Ruegg, Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea, Histochemistry and Cell Biology, 2012, 137, 6, 811

    CrossRef

  32. 32
    Alexander Spassov, Tomasz Gredes, Dragan Pavlovic, Tomasz Gedrange, Christian Lehmann, Silke Lucke, Christiane Kunert-Keil, Talin, Vinculin and Nestin Expression in Orofacial Muscles of Dystrophin Deficient mdx Mice, Archivum Immunologiae et Therapiae Experimentalis, 2012, 60, 2, 137

    CrossRef

  33. 33
    A.T. Piers, T. Lavin, H.G. Radley-Crabb, A.J. Bakker, M.D. Grounds, G.J. Pinniger, Blockade of TNF in vivo using cV1q antibody reduces contractile dysfunction of skeletal muscle in response to eccentric exercise in dystrophic mdx and normal mice, Neuromuscular Disorders, 2011, 21, 2, 132

    CrossRef

  34. 34
    Erica C. Campos, João L. O'Connell, Lygia M. Malvestio, Minna M. Dias Romano, Simone G. Ramos, Mara Rúbia N. Celes, Cibele M. Prado, Marcus V. Simões, Marcos A. Rossi, Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy, European Journal of Pharmacology, 2011, 670, 2-3, 541

    CrossRef

  35. 35
    Christopher F. Spurney, Cardiomyopathy of duchenne muscular dystrophy: Current understanding and future directions, Muscle & Nerve, 2011, 44, 1
  36. 36
    Anna Cozzoli, Beatrice Nico, Valeriana Teresa Sblendorio, Roberta Francesca Capogrosso, Maria Maddalena Dinardo, Vito Longo, Sara Gagliardi, Monica Montagnani, Annamaria De Luca, Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice, Pharmacological Research, 2011, 64, 5, 482

    CrossRef

  37. 37
    Louise H. Jørgensen, Alison Blain, Elizabeth Greally, Steve H. Laval, Andrew M. Blamire, Benjamin J. Davison, Heinrich Brinkmeier, Guy A. MacGowan, Henrik D. Schrøder, Kate Bushby, Volker Straub, Hanns Lochmüller, Long-Term Blocking of Calcium Channels in mdx Mice Results in Differential Effects on Heart and Skeletal Muscle, The American Journal of Pathology, 2011, 178, 1, 273

    CrossRef

  38. 38
    Taeyoung Koo, Takashi Okada, Takis Athanasopoulos, Helen Foster, Shin'ichi Takeda, George Dickson, Long-term functional adeno-associated virus-microdystrophin expression in the dystrophic CXMDj dog, The Journal of Gene Medicine, 2011, 13, 9
  39. 39
    Youssef Hibaoui, Julie Reutenauer-Patte, Ophélie Patthey-Vuadens, Urs T. Ruegg, Olivier M. Dorchies, Melatonin improves muscle function of the dystrophic mdx5Cv mouse, a model for Duchenne muscular dystrophy, Journal of Pineal Research, 2011, 51, 2
  40. 40
    Sanjeewa A. Goonasekera, Chi K. Lam, Douglas P. Millay, Michelle A. Sargent, Roger J. Hajjar, Evangelia G. Kranias, Jeffery D. Molkentin, Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle, Journal of Clinical Investigation, 2011, 121, 3, 1044

    CrossRef

  41. 41
    J. Lerman, Perioperative management of the paediatric patient with coexisting neuromuscular disease, British Journal of Anaesthesia, 2011, 107, suppl 1, i79

    CrossRef

  42. 42
    Daniel P. Reay, Michele Yang, Jon F. Watchko, Molly Daood, Terrence L. O'Day, Khaleel K. Rehman, Denis C. Guttridge, Paul D. Robbins, Paula R. Clemens, Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology, Neurobiology of Disease, 2011, 43, 3, 598

    CrossRef

  43. 43
    Jessica D. Gumerson, Daniel E. Michele, The Dystrophin-Glycoprotein Complex in the Prevention of Muscle Damage, Journal of Biomedicine and Biotechnology, 2011, 2011, 1

    CrossRef

  44. 44
    Kristen A Baltgalvis, Michele A Jaeger, Daniel P Fitzsimons, Stanley A Thayer, Dawn A Lowe, James M Ervasti, Transgenic overexpression of γ-cytoplasmic actin protects against eccentric contraction-induced force loss in mdx mice, Skeletal Muscle, 2011, 1, 1, 32

    CrossRef

  45. 45
    Maaike van Putten, Christa de Winter, Willeke van Roon-Mom, Gert-Jan van Ommen, Peter A.C. ’t Hoen, Annemieke Aartsma-Rus, A 3 months mild functional test regime does not affect disease parameters in young mdx mice, Neuromuscular Disorders, 2010, 20, 4, 273

    CrossRef

  46. 46
    G. F. Simões, A. L. R. Oliveira, Alpha motoneurone input changes in dystrophic MDX mice after sciatic nerve transection, Neuropathology and Applied Neurobiology, 2010, 36, 1
  47. 47
    Adriana Pertille, Candida Luiza Tonizza De Carvalho, Cintia Yuri Matsumura, Humberto Santo Neto, Maria Julia Marques, Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy, International Journal of Experimental Pathology, 2010, 91, 1
  48. 48
    Gerald S. Supinski, Leigh Ann Callahan, Calpain Activation Contributes to Endotoxin-Induced Diaphragmatic Dysfunction, American Journal of Respiratory Cell and Molecular Biology, 2010, 42, 1, 80

    CrossRef

  49. 49
    Abdallah Fayssoil, Olivier Nardi, David Orlikowski, Djillali Annane, Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics, Heart Failure Reviews, 2010, 15, 1, 103

    CrossRef

  50. 50
    Tommaso Iannitti, Stefania Capone, David Feder, Beniamino Palmieri, Clinical Use of Immunosuppressants in Duchenne Muscular Dystrophy, Journal of Clinical Neuromuscular Disease, 2010, 12, 1, 1

    CrossRef

  51. 51
    Erin R. Wissing, Douglas P. Millay, Grégoire Vuagniaux, Jeffery D. Molkentin, Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice, Neuromuscular Disorders, 2010, 20, 11, 753

    CrossRef

  52. 52
    Mara Rúbia N Celes, Diego Torres-Dueñas, Lygia M Malvestio, Valdecir Blefari, Erica C Campos, Simone G Ramos, Cibele M Prado, Fernando Q Cunha, Marcos A Rossi, Disruption of sarcolemmal dystrophin and β-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis, Laboratory Investigation, 2010, 90, 4, 531

    CrossRef

  53. 53
    Anderson Neri Guido, Gerson Eduardo Rocha Campos, Humberto Santo Neto, Maria Julia Marques, Elaine Minatel, Fiber Type Composition of the Sternomastoid and Diaphragm Muscles of Dystrophin-Deficient mdx Mice, The Anatomical Record, 2010, 293, 10
  54. 54
    Nicholas P. Evans, Jarrod A. Call, Josep Bassaganya-Riera, John L. Robertson, Robert W. Grange, Green tea extract decreases muscle pathology and NF-κB immunostaining in regenerating muscle fibers of mdx mice, Clinical Nutrition, 2010, 29, 3, 391

    CrossRef

  55. 55
    Xiaoli Zhao, Choon Kee Min, Jae-Kyun Ko, Jerome Parness, Do Han Kim, Noah Weisleder, Jianjie Ma, Increased Store-Operated Ca2+ Entry in Skeletal Muscle with Reduced Calsequestrin-1 Expression, Biophysical Journal, 2010, 99, 5, 1556

    CrossRef

  56. 56
    Mariam Chahbouni, Germaine Escames, Carmen Venegas, Belén Sevilla, José Antonio García, Luis C. López, Antonio Muñoz-Hoyos, Antonio Molina-Carballo, Darío Acuña-Castroviejo, Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy, Journal of Pineal Research, 2010, 48, 3
  57. 57
    O. Friedrich, M. Both, C. Weber, S. Schürmann, M.D.H. Teichmann, F. von Wegner, R.H.A. Fink, M. Vogel, J.S. Chamberlain, C. Garbe, Microarchitecture Is Severely Compromised but Motor Protein Function Is Preserved in Dystrophic mdx Skeletal Muscle, Biophysical Journal, 2010, 98, 4, 606

    CrossRef

  58. 58
    S. Menazza, B. Blaauw, T. Tiepolo, L. Toniolo, P. Braghetta, B. Spolaore, C. Reggiani, F. Di Lisa, P. Bonaldo, M. Canton, Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy, Human Molecular Genetics, 2010, 19, 21, 4207

    CrossRef

  59. 59
    C. Colussi, C. Banfi, M. Brioschi, E. Tremoli, S. Straino, F. Spallotta, Antonello Mai, Dante Rotili, M. C. Capogrossi, Carlo Gaetano, Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment, PROTEOMICS - Clinical Applications, 2010, 4, 1
  60. 60
    María Teresa Moral-Naranjo, María Fernanda Montenegro, Encarnación Muñoz-Delgado, Francisco J. Campoy, Cecilio J. Vidal, The levels of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice with muscular dystrophy by merosin deficiency, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 9, 754

    CrossRef

  61. 61
    Gonneke S. K. Pilgram, Saranyapin Potikanond, Richard A. Baines, Lee G. Fradkin, Jasprina N. Noordermeer, The Roles of the Dystrophin-Associated Glycoprotein Complex at the Synapse, Molecular Neurobiology, 2010, 41, 1, 1

    CrossRef

  62. 62
    Elisabetta Gazzerro, Stefania Assereto, Andrea Bonetto, Federica Sotgia, Sonia Scarfì, Angela Pistorio, Gloria Bonuccelli, Michele Cilli, Claudio Bruno, Federico Zara, Michael P. Lisanti, Carlo Minetti, Therapeutic Potential of Proteasome Inhibition in Duchenne and Becker Muscular Dystrophies, The American Journal of Pathology, 2010, 176, 4, 1863

    CrossRef

  63. 63
    Felicity J. Waters, Thea Shavlakadze, Matthew J. McIldowie, Matthew J. Piggott, Miranda D. Grounds, Use of pifithrin to inhibit p53-mediated signalling of TNF in dystrophic muscles of mdx mice, Molecular and Cellular Biochemistry, 2010, 337, 1-2, 119

    CrossRef

  64. 64
    D. P. Millay, S. A. Goonasekera, M. A. Sargent, M. Maillet, B. J. Aronow, J. D. Molkentin, Calcium influx is sufficient to induce muscular dystrophy through a TRPC-dependent mechanism, Proceedings of the National Academy of Sciences, 2009, 106, 45, 19023

    CrossRef

  65. 65
    Cintia Yuri Matsumura, Adriana Pertille, Tereza C.P. Albuquerque, Humberto Santo Neto, Maria Julia Marques, Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: A potential role in calcium buffering and sarcolemmal stability, Muscle & Nerve, 2009, 39, 2
  66. 66
    Nicholas P. Evans, Sarah A. Misyak, John L. Robertson, Josep Bassaganya-Riera, Robert W. Grange, Dysregulated Intracellular Signaling and Inflammatory Gene Expression During Initial Disease Onset in Duchenne Muscular Dystrophy, American Journal of Physical Medicine & Rehabilitation, 2009, 88, 6, 502

    CrossRef

  67. 67
    Nicholas P. Evans, Sarah A. Misyak, John L. Robertson, Josep Bassaganya-Riera, Robert W. Grange, Immune-Mediated Mechanisms Potentially Regulate the Disease Time-Course of Duchenne Muscular Dystrophy and Provide Targets for Therapeutic Intervention, PM&R, 2009, 1, 8, 755

    CrossRef

  68. 68
    Jiali Tan, Wei Kuang, Zuolin Jin, Fang Jin, Lin Xu, Qiujun Yu, Liang Kong, Guang Zeng, Xiao Yuan, Yinzhong Duan, Inhibition of NFkappaB by activated c-Jun NH2 terminal kinase 1 acts as a switch for C2C12 cell death under excessive stretch, Apoptosis, 2009, 14, 6, 764

    CrossRef

  69. 69
    Harshad Gurnaney, Amanda Brown, Ronald S. Litman, Malignant Hyperthermia and Muscular Dystrophies, Anesthesia & Analgesia, 2009, 109, 4, 1043

    CrossRef

  70. 70
    Graham D. Lamb, Mechanisms of excitation-contraction uncoupling relevant to activity-induced muscle fatigueThis paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process., Applied Physiology, Nutrition, and Metabolism, 2009, 34, 3, 368

    CrossRef

  71. 71
    Youssef Hibaoui, Emmanuelle Roulet, Urs T. Ruegg, Melatonin prevents oxidative stress-mediated mitochondrial permeability transition and death in skeletal muscle cells, Journal of Pineal Research, 2009, 47, 3
  72. 72
    Kevin B. Walters, M. Ernest Dodd, Jonathan R. Mathias, Andrea J. Gallagher, David A. Bennin, Jennifer Rhodes, John P. Kanki, A. Thomas Look, Yevgenya Grinblat, Anna Huttenlocher, Muscle degeneration and leukocyte infiltration caused by mutation of zebrafish fad24, Developmental Dynamics, 2009, 238, 1
  73. 73
    Olivier M. Dorchies, Stéphanie Wagner, Timo M. Buetler, Urs T. Ruegg, Protection of dystrophic muscle cells with polyphenols from green tea correlates with improved glutathione balance and increased expression of 67LR, a receptor for (−)-epigallocatechin gallate, BioFactors, 2009, 35, 3
  74. 74
    Renato Ferretti, Maria Julia Marques, Adriana Pertille, Humberto Santo Neto, Sarcoplasmic–endoplasmic–reticulum Ca2+-ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin-deficient mdx mice, Muscle & Nerve, 2009, 39, 5
  75. 75
    James A. Ridgley, Gavin J. Pinniger, Peter W. Hamer, Miranda D. Grounds, The physiological effects of IGF-1 (class 1:Ea transgene) over-expression on exercise-induced damage and adaptation in dystrophic muscles of mdx mice, Pflügers Archiv - European Journal of Physiology, 2009, 457, 5, 1121

    CrossRef

  76. 76
    Jerome Parness, Jerrold Lerman, Robert C. Stough, A Practice of Anesthesia for Infants and Children, 2009,

    CrossRef

  77. 77
    B. Blaauw, C. Mammucari, L. Toniolo, L. Agatea, R. Abraham, M. Sandri, C. Reggiani, S. Schiaffino, Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle, Human Molecular Genetics, 2008, 17, 23, 3686

    CrossRef

  78. You have free access to this content78
    Maria Julia Marques, Rafael Ventura Machado, Elaine Minatel, Humberto Santo Neto, Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness, Muscle & Nerve, 2008, 37, 1
  79. 79
    Douglas P Millay, Michelle A Sargent, Hanna Osinska, Christopher P Baines, Elisabeth R Barton, Grégoire Vuagniaux, H Lee Sweeney, Jeffrey Robbins, Jeffery D Molkentin, Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy, Nature Medicine, 2008, 14, 4, 442

    CrossRef

  80. 80
    Miranda D Grounds, Hannah G Radley, Bijanka L Gebski, Marie A Bogoyevitch, Thea Shavlakadze, IMPLICATIONS OF CROSS-TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN-LIKE GROWTH FACTOR-1 SIGNALLING IN SKELETAL MUSCLE, Clinical and Experimental Pharmacology and Physiology, 2008, 35, 7
  81. 81
    Peter G Arthur, Miranda D Grounds, Thea Shavlakadze, Oxidative stress as a therapeutic target during muscle wasting: considering the complex interactions, Current Opinion in Clinical Nutrition and Metabolic Care, 2008, 11, 4, 408

    CrossRef

  82. 82
    Emidio E. Pistilli, Stephen E. Alway, Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats, Biochemical and Biophysical Research Communications, 2008, 373, 1, 20

    CrossRef

  83. 83
    Miranda D. Grounds, Hannah G. Radley, Gordon S. Lynch, Kanneboyina Nagaraju, Annamaria De Luca, Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy, Neurobiology of Disease, 2008, 31, 1, 1

    CrossRef

  84. 84
    H.G. Radley, A. De Luca, G.S. Lynch, M.D. Grounds, Duchenne muscular dystrophy: Focus on pharmaceutical and nutritional interventions, The International Journal of Biochemistry & Cell Biology, 2007, 39, 3, 469

    CrossRef

  85. 85
    I. Gáti, O. Danielsson, T. Betmark, J. Ernerudh, K. Öllinger, N. Dizdar, Effects of inhibitors of the arachidonic acid cascade on primary muscle culture from a Duchenne muscular dystrophy patient, Prostaglandins, Leukotrienes and Essential Fatty Acids, 2007, 77, 3-4, 217

    CrossRef

  86. 86
    Jeffry B Lansman, Alfredo Franco-Obregón, MECHANOSENSITIVE ION CHANNELS IN SKELETAL MUSCLE: A LINK IN THE MEMBRANE PATHOLOGY OF MUSCULAR DYSTROPHY, Clinical and Experimental Pharmacology and Physiology, 2006, 33, 7
  87. 87
    Jian Tang, Susie Tang, Maryann Haldi, Wen Lin Seng, Zebrafish Assays for Identifying Potential Muscular Dystrophy Drug Candidates,